Ines B.
- Country
- Germany
- Department
- Klinik f. Kinder- und Jugendmedizin
Research Overview
- Nivolumab in combination with cisplatin and 5-fluorouracil as induction therapy in children and adults with EBV-positive nasopharyngeal carcinoma
- Evaluation of Pharmacokinetics, Safety, and Efficacy of Selumetinib Granule Formulation in Pediatric Patients with NF1-Related Inoperable Plexiform Neurofibromas
Data & Insights
Has run more than one trial at 2 of 33 partner sites.
Specializations
Oncology Focus
This investigator specializes in the treatment of nasopharyngeal carcinoma, with particular emphasis on EBV-positive cases. Their work involves innovative combination therapy approaches using targeted immunotherapy alongside traditional treatment methods.
- Nasopharyngeal Cancer Treatment
- Immunotherapy Applications
- Combined Therapeutic Approaches
The research explores optimized treatment protocols for both pediatric and adult populations.
Pediatric Therapeutics
The investigator conducts specialized research in pediatric medicine, focusing on rare genetic conditions and their treatment in young patients. Their work emphasizes age-appropriate therapeutic formulations for children between 1 and 7 years.
- Pediatric Drug Development
- Age-Specific Formulations
- Child-Focused Treatment Protocols
Their approach incorporates careful consideration of pediatric-specific dosing and administration methods.
Genetic Disorders
The investigator has developed expertise in treating Neurofibromatosis Type 1, particularly focusing on managing plexiform neurofibromas. Their research addresses complex cases involving inoperable tumors and symptomatic manifestations.
- Neurofibromatosis Management
- Targeted Therapeutic Solutions
- Novel Drug Formulations
The work encompasses pharmacokinetic studies and safety evaluations of innovative treatment approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.